Results 41 to 50 of about 5,973 (205)
Propafenone for conversion and prophylaxis of atrial fibrillation
, 1997 Pharmacologic therapy is widely used for restoration of sinus rhythm and prevention of recurrences of atrial fibrillation. Because concerns have been raised about their potential proarrhythmic effects, therapeutic regimens should be evaluated by placebo ...
Stiels, B. +3 more
core +1 more source
Catheterization and Cardiovascular Interventions, Volume 108, Issue 3, Page 924-934, September 1, 2026.ABSTRACT Background A 3D electroanatomical mapping (3D‐EAM) visualized steerable sheath was designed to improve catheter placement and reduce radiation exposure during ablation, an established treatment for atrial fibrillation (AF). However, prospective randomized data comparing the procedural and clinical outcomes of visualized and non‐visualized ...
Chun‐Kai Chen +4 more
wiley +1 more source
Comparison of the pharmacodynamic effects of intravenous and oral propafenone.
, 1990 The effect of propafenone and its major metabolite 5-hydroxy-propafenone on ECG intervals was investigated in eight healthy extensive metabolizers after single oral (300 to 450 mg) and intravenous (35 to 50 mg) doses of propafenone in a single-blind ...
Follath F, Ha HR, Haefeli EW, Vozeh S
core +1 more source
Clinical Cardiology, Volume 49, Issue 9, September 2026.LAAS and LAASR were independent factors contributing to AF recurrence. Incremental value of LAAS and LAASR in risk prediction of AF recurrence. ABSTRACT Purpose The aim of this study is to evaluate left atrium (LA) and left atrial appendage (LAA) remodeling using two‐dimensional speckle tracking echocardiography (2D‐STE) and investigate its predictive ...
Binyang Zhu +7 more
wiley +1 more source
Randomized placebo-controlled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery [PDF]
, 1987 Fourteen patients with atrial fibrillation or flutter and a ventricular rate of ≥120 beats/min occurring after cardiac surgery entered a double-blind placebo-controlled conditional crossover trial of intravenous propafenone.
Mulji, Amin S. +9 more
core +1 more source
Annals of Noninvasive Electrocardiology, Volume 31, Issue 5, September 2026.In NHANES III adults, latent class trajectory analysis identified a J‐point phenotype characterized by higher V4 amplitude and a steep decline toward V6. This spatial trajectory was independently associated with increased long‐term all‐cause mortality and cardiac death, suggesting prognostic value beyond conventional early repolarization criteria ...
Chenhui Tai, Zhe Wang
wiley +1 more source
, 2018 For this poster presented at the Natural Science Poster Session at Parkland College, the student chose the drug Propafenone, also known as Rythmol, whose labeled uses are to treat ventricular arrhythmias, atrial fibrillation, and paroxysmal ...
Figueiredo, Maria
core
Effects of propafenone on sinus node function in the rabbit heart
, 1990 Propafenone is a type 1C antiarrhythmic drug with efficacy for both ventricular and supraventricular arrhythmias. We investigated the effects of propafenone on properties of sinus node function in an in vitro preparation of rabbit sinus node and ...
Charles R. Kerr
core +1 more source
Acta Ophthalmologica, Volume 104, Issue 6, Page e630-e647, September 2026.Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen +3 more
wiley +1 more source
Acute Propafenone Toxicity Discovered after Unknown Onset of Symptoms
, 2013 Propafenone is a class 1C antiarrhythmic with sodium channel and beta blocking properties. At toxic doses it causes wide range of arrhythmias including cardiac conduction abnormalities, AV block and prolongation of QRS complexes that may be fatal.
Solakoğlu, Görkem Alper +4 more
core +1 more source